The gut microbiota perspective for interventions in MS

Area of Science:

• Immunology
• Microbiology
• Neurology

Background:

• Autoimmune disorders, including multiple sclerosis (MS), involve complex interactions between genetic and environmental factors.
• The gut microbiome is increasingly recognized as a significant environmental factor influencing MS etiology and treatment outcomes.
• Variations in gut microbiota composition and function impact host metabolism, gut barrier integrity, and immune system modulation.

Purpose of the Study:

• To review the impact of gut microbiome alterations on multiple sclerosis (MS) pathophysiology.
• To explore the potential of microbiome-targeted therapies for MS and other autoimmune conditions.
• To highlight the need for improved therapeutic strategies based on a deeper understanding of the gut microbiome's role.

Main Methods:

• Literature review and synthesis of current research on the gut microbiome and MS.
• Analysis of studies detailing changes in gut microbiota composition, metabolism, and immune system interactions in MS patients.
• Examination of existing and potential therapeutic interventions targeting the gut microbiome.

Main Results:

• Gut microbiome dysbiosis, including quantitative and functional changes, is implicated in MS.
• Microbiome alterations affect gut permeability, homeostasis, and immune cell modulation relevant to MS.
• Current microbiome-based interventions for autoimmune disorders are preliminary and require refinement.

Conclusions:

• The gut microbiome plays a critical role in the pathophysiology of multiple sclerosis.
• Targeting the gut microbiome offers a promising avenue for novel therapeutic strategies in MS.
• Further research is needed to translate microbiome knowledge into effective clinical interventions for autoimmune diseases.